DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 64 filers reported holding DERMA SCIENCES INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,857,000 | +84.0% | 549,341 | +65.2% | 0.02% | +80.0% |
| Q3 2016 | $1,553,000 | +69.5% | 332,521 | +43.0% | 0.01% | +66.7% |
| Q2 2016 | $916,000 | +24.5% | 232,521 | -2.1% | 0.01% | +20.0% |
| Q1 2016 | $736,000 | -32.2% | 237,507 | 0.0% | 0.01% | -16.7% |
| Q4 2015 | $1,085,000 | +4.0% | 237,507 | +7.2% | 0.01% | 0.0% |
| Q3 2015 | $1,043,000 | -62.9% | 221,507 | -43.6% | 0.01% | -50.0% |
| Q2 2015 | $2,810,000 | -3.2% | 392,500 | +14.6% | 0.01% | +9.1% |
| Q1 2015 | $2,902,000 | +92.3% | 342,600 | +111.4% | 0.01% | +120.0% |
| Q4 2014 | $1,509,000 | +229.5% | 162,100 | +194.7% | 0.01% | +150.0% |
| Q3 2014 | $458,000 | -28.0% | 55,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $636,000 | -8.8% | 55,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $697,000 | +17.1% | 55,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $595,000 | – | 55,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,185,632 | $11,038,000 | 5.31% |
| DAFNA Capital Management LLC | 384,794 | $3,582,000 | 2.83% |
| Consonance Capital Management LP | 1,632,627 | $15,200,000 | 1.96% |
| Broadfin Capital, LLC | 3,713,754 | $34,576,000 | 1.50% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 265,946 | $2,476,000 | 0.85% |
| Senvest Management, LLC | 1,151,926 | $10,724,000 | 0.76% |
| HealthCor Management, L.P. | 920,000 | $8,565,000 | 0.48% |
| J. Goldman & Co LP | 365,000 | $3,398,000 | 0.40% |
| Baker Brothers Advisors | 3,537,137 | $32,931,000 | 0.34% |
| Perceptive Advisors | 313,583 | $2,919,000 | 0.24% |